Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
13.50
+0.37 (2.82%)
At close: May 12, 2025, 4:00 PM
13.24
-0.26 (-1.93%)
After-hours: May 12, 2025, 4:41 PM EDT
Sotera Health Company Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$15.80
Upside
+17.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $14 → $17 | Hold → Strong Buy | Upgrades | $14 → $17 | +25.93% | May 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | -3.70% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | -11.11% | Apr 10, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +18.52% | Feb 28, 2025 |
| Barclays | Barclays | Buy Maintains $18 → $17 | Buy | Maintains | $18 → $17 | +25.93% | Feb 18, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +25.93% | Nov 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +48.15% | Nov 6, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $17 | Buy | Maintains | $14 → $17 | +25.93% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +25.93% | Aug 6, 2024 |
| Piper Sandler | Piper Sandler | Hold Initiates $13 | Hold | Initiates | $13 | -3.70% | May 21, 2024 |
| Barclays | Barclays | Buy Maintains $19 → $14 | Buy | Maintains | $19 → $14 | +3.70% | Apr 10, 2024 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $18 → $16 | Hold → Strong Buy | Upgrades | $18 → $16 | +18.52% | Apr 3, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $15 → $16 | Hold → Strong Buy | Upgrades | $15 → $16 | +14.81% | Mar 25, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +48.15% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $20 | Buy | Reiterates | $20 | +48.15% | Mar 4, 2024 |
| Barclays | Barclays | Buy Maintains $17 → $19 | Buy | Maintains | $17 → $19 | +40.74% | Feb 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.